SIGLEC9 and cervical cancer: In addition, the authors collected single-cell suspension from cervical cancer tissues and normal controls, and detected the proportion of SIGLEC9+ CD4+T-cells, SIGLEC9+ CD8+T-cells and SIGLEC9+ M1 macrophages and SIGLEC9+ TAMs by flow cytometry.